ArticleMolecular cancer therapeutics2025
Zidesamtinib Selective Targeting of Diverse ROS1 Drug-Resistant Mutations.
Anupong Tangpeerachaikul et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this paperpooled itcites it